Valens can now ship products to five provinces
and one territory in Canada
KELOWNA, BC, April 21, 2021 /CNW/ - The Valens Company
Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company," "The
Valens Company" or "Valens"), a leading
manufacturer of cannabis products, today announced its entry into
the Yukon market with a cannabis
purchase and sale agreement with the Yukon Liquor Corporation
(YLC).
The agreement allows for the sale and distribution of
Valens-manufactured products to licensed cannabis retailers in
Yukon and on Cannabis Yukon, Yukon Liquor Corporation's ecommerce
platform. Valens expects to bring a range of Cannabis 2.0 and 3.0
products to the Yukon market,
which could include vapes, concentrates, beverages, topicals and
edibles, expanding the variety of innovative formats available in
the territory.
"Our entry into the Yukon
market not only furthers our ability to capture market share in
Canada, but also broadens the
selection and quality of products that consumers in the territory
can access," said Tyler Robson, CEO,
Co-Founder and Chair of The Valens Company. "We have made
significant progress growing our cannabis distribution network and
we expect to increase our national position in the short-term as we
continue discussions with other private and government-regulated
retailers across the country."
Valens-manufactured products will be shipped to Yukon and available to consumers in the coming
quarters.
At Valens, it's Personal.
About The Valens Company
The Valens Company is a
leading manufacturer of cannabis products with a mission to bring
the benefits of cannabis to the world. The Company provides
proprietary cannabis processing services across five core
technologies, in addition to best-in-class product development,
formulation and manufacturing of cannabis consumer packaged goods.
The Valens Company's high-quality products are exclusively
formulated for the medical, therapeutic, health and wellness, and
recreational consumer segments, and are offered across numerous
product formats, including oils, vapes, concentrates, edibles and
topicals, as well as pre-rolls, with a focus on next-generation
product development and innovation. Its breakthrough patented
emulsification technology, SōRSE™ by Valens, converts cannabis oil
into water-soluble emulsions for seamless integration into a
variety of product formats, allowing for near-perfect dosing,
stability, and taste. In partnership with brand houses, consumer
packaged goods companies and licensed cannabis producers around the
globe, the Company continues to grow its diverse product portfolio
in alignment with evolving cannabis consumer preferences in key
markets. Through its wholly owned subsidiary Valens Labs Ltd., the
Company is setting the standard in cannabis testing and research
and development with Canada's only
ISO17025 accredited analytical services lab, named The Centre of
Excellence in Plant-Based Science by partner and scientific world
leader Thermo Fisher Scientific. Discover more on The Valens
Company and its subsidiaries at
http://www.thevalenscompany.com.
Notice regarding Forward Looking Statements
All
information included in this press release, including any
information as to the future financial or operating performance and
other statements of The Valens Company that express management's
expectations or estimates of future performance, other than
statements of historical fact, constitute forward-looking
information or forward-looking statements within the meaning of
applicable securities laws and are based on expectations, estimates
and projections as of the date hereof. Forward-looking statements
are included for the purpose of providing information about
management's current expectations and plans relating to the future.
Wherever possible, words such as "plans", "expects", "scheduled",
"trends", "forecasts", "future", "indications", "potential",
"estimates", "predicts", "anticipate", "to establish", "believe",
"intend", "ability to", or statements that certain actions, events
or results "may", "should", "could", "would", "might", "will", or
are "likely" to be taken, occur or be achieved, or the negative of
these words or other variations thereof, have been used to identify
such forward-looking information. Specific forward-looking
statements include, without limitation, all disclosure regarding
future results of operations, future outcomes of transactions,
economic conditions, and anticipated courses of action. Investors
and other parties are advised that there is not necessarily any
correlation between the number of SKUs manufactured and shipped and
revenue and profit, and undue reliance should not be placed on such
information.
The risks and uncertainties that may affect forward-looking
statements include, among others, Canadian regulatory risk,
Australian regulatory risk, U.S. regulatory risk, U.S. border
crossing and travel bans, the uncertainties, effects of and
responses to the COVID-19 pandemic, reliance on licenses, expansion
of facilities, competition, dependence on supply of cannabis and
reliance on other key inputs, dependence on senior management and
key personnel, general business risk and liability, regulation of
the cannabis industry, change in laws, regulations and guidelines,
compliance with laws, limited operating history, vulnerability to
rising energy costs, unfavourable publicity or consumer perception,
product liability, risks related to intellectual property, product
recalls, difficulties with forecasts, management of growth and
litigation, many of which are beyond the control of The Valens
Company. For a more comprehensive discussion of the risks faced by
The Valens Company, and which may cause the actual financial
results, performance or achievements of The Valens Company to be
materially different from estimated future results, performance or
achievements expressed or implied by forward-looking information or
forward-looking statements, please refer to The Valens Company's
latest Annual Information Form filed with Canadian securities
regulatory authorities at www.sedar.com or on The Valens Company's
website at www.thevalenscompany.com. The risks described in such
Annual Information Form are hereby incorporated by reference
herein. Although the forward-looking statements contained herein
reflect management's current beliefs and reasonable assumptions
based upon information available to management as of the date
hereof, The Valens Company cannot be certain that actual results
will be consistent with such forward-looking information. The
Valens Company cautions you not to place undue reliance upon any
such forward-looking statements. The Valens Company disclaims any
intention or obligation to update or revise any forward-looking
statements whether as a result of new information, future events or
otherwise, except as required by applicable law. Nothing herein
should be construed as either an offer to sell or a solicitation to
buy or sell securities of The Valens Company.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/the-valens-company-increases-domestic-reach-with-distribution-agreement-with-yukon-territory-301274267.html
SOURCE The Valens Company Inc.